-
公开(公告)号:US20220033824A1
公开(公告)日:2022-02-03
申请号:US17297521
申请日:2019-11-27
IPC分类号: C12N15/113 , C12N15/86 , C12N15/10 , A61K35/761
摘要: The disclosure provides, in some aspects, compositions (e.g., isolated nucleic acids and rAAVs) comprising a transgene which encodes at least one inhibitory nucleic acid which decreases expression of a gene encoding a serine palmitoyltransferase protein (e.g., SPTLC1). In some aspects, the disclosure relates to methods of treating hereditary sensory and autonomic neuropathy 1 (HSAN1) by administering the compositions described by the disclosure to a cell or subject.